Mtld的诱导表达促进了长聚球菌PCC 7942中甘露醇合成途径的引入。

IF 4.3 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-03-21 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1575266
Jiahui Sun, Jinyu Cui, Xuejing Xu, Jinhui Tang, Huili Sun, Xiangxiao Liu, Xiangyi Yuan, Guodong Luan, Xuefeng Lu
{"title":"Mtld的诱导表达促进了长聚球菌PCC 7942中甘露醇合成途径的引入。","authors":"Jiahui Sun, Jinyu Cui, Xuejing Xu, Jinhui Tang, Huili Sun, Xiangxiao Liu, Xiangyi Yuan, Guodong Luan, Xuefeng Lu","doi":"10.3389/fbioe.2025.1575266","DOIUrl":null,"url":null,"abstract":"<p><p>Mannitol is a valuable sugar alcohol, extensively used across various industries. Cyanobacteria show potential as future platforms for mannitol production, utilizing CO<sub>2</sub> and solar energy directly. The proof-of-concept has been demonstrated by introducing a two-step pathway in cyanobacteria, converting fructose-6-phosphate to mannitol-1-phosphate and sequentially to mannitol. However, recombinant strains generally faced issues of genetic instability or low titers, consequently affecting the long-term mannitol production. In this work, the construction strategy for engineering mannitol production in <i>Synechococcus elongatus</i> PCC 7942, based on commonly adopted pathway comprising mannitol-1-phosphate dehydrogenase (Mtld) and mannitol-1-phosphatase (M1Pase), was optimized. The results demonstrated that the sequential introduction of <i>m1p</i> and <i>mtld</i> was required to obtain mannitol-producing strains. We further manipulated the abundances of Mtld with a theophylline dose-responsive riboswitch approach, and by combining it with the overexpression of <i>m1p</i>, we successfully obtained a recombinant strain producing 1.5 g/L mannitol under optimal conditions, the highest cyanobacterial yield to date. In addition, the controlled expression of <i>mtld</i> was demonstrated to remarkably augment the genetic stability of the mutant under long-term culturing circumstances, which continued to secrete mannitol after more than 2 months of cultivation without the addition of theophylline, and the mannitol biosynthesis operon did not undergo any spontaneous mutation. The findings in this work provided novel insights into the area of cyanobacteria mannitol metabolism engineering, and would inspire researchers to construct strains with different gene regulatory strategies for efficient photosynthetic biosynthesis.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1575266"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11968706/pdf/","citationCount":"0","resultStr":"{\"title\":\"Inducible Mtld expression facilitated the introduction of the mannitol synthesis pathway in <i>Synechococcus elongatus</i> PCC 7942.\",\"authors\":\"Jiahui Sun, Jinyu Cui, Xuejing Xu, Jinhui Tang, Huili Sun, Xiangxiao Liu, Xiangyi Yuan, Guodong Luan, Xuefeng Lu\",\"doi\":\"10.3389/fbioe.2025.1575266\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Mannitol is a valuable sugar alcohol, extensively used across various industries. Cyanobacteria show potential as future platforms for mannitol production, utilizing CO<sub>2</sub> and solar energy directly. The proof-of-concept has been demonstrated by introducing a two-step pathway in cyanobacteria, converting fructose-6-phosphate to mannitol-1-phosphate and sequentially to mannitol. However, recombinant strains generally faced issues of genetic instability or low titers, consequently affecting the long-term mannitol production. In this work, the construction strategy for engineering mannitol production in <i>Synechococcus elongatus</i> PCC 7942, based on commonly adopted pathway comprising mannitol-1-phosphate dehydrogenase (Mtld) and mannitol-1-phosphatase (M1Pase), was optimized. The results demonstrated that the sequential introduction of <i>m1p</i> and <i>mtld</i> was required to obtain mannitol-producing strains. We further manipulated the abundances of Mtld with a theophylline dose-responsive riboswitch approach, and by combining it with the overexpression of <i>m1p</i>, we successfully obtained a recombinant strain producing 1.5 g/L mannitol under optimal conditions, the highest cyanobacterial yield to date. In addition, the controlled expression of <i>mtld</i> was demonstrated to remarkably augment the genetic stability of the mutant under long-term culturing circumstances, which continued to secrete mannitol after more than 2 months of cultivation without the addition of theophylline, and the mannitol biosynthesis operon did not undergo any spontaneous mutation. The findings in this work provided novel insights into the area of cyanobacteria mannitol metabolism engineering, and would inspire researchers to construct strains with different gene regulatory strategies for efficient photosynthetic biosynthesis.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1575266\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11968706/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1575266\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1575266","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

甘露醇是一种有价值的糖醇,广泛用于各行各业。蓝藻显示出作为未来甘露醇生产平台的潜力,直接利用二氧化碳和太阳能。通过在蓝藻菌中引入两步途径,将果糖-6-磷酸转化为甘露醇-1-磷酸,然后依次转化为甘露醇,证明了概念验证。然而,重组菌株普遍面临遗传不稳定或低滴度的问题,从而影响长期甘露醇的生产。本研究以甘露醇-1-磷酸脱氢酶(Mtld)和甘露醇-1-磷酸酶(M1Pase)为主要途径,对长聚球菌PCC 7942产甘露醇工程菌的构建策略进行了优化。结果表明,要获得生产甘露醇的菌株,需要依次引入m1p和mtld。我们进一步利用茶碱剂量响应的核糖开关方法来操纵Mtld的丰度,并将其与m1p的过表达结合,我们成功地获得了在最佳条件下生产1.5 g/L甘露醇的重组菌株,这是迄今为止最高的蓝藻产量。此外,mtld的控制表达在长期培养环境下显著增强了突变体的遗传稳定性,在没有添加茶碱的情况下,突变体在培养2个多月后仍在分泌甘露醇,甘露醇生物合成操纵子没有发生任何自发突变。本研究结果为蓝藻甘露醇代谢工程领域提供了新的见解,并将启发研究人员构建具有不同基因调控策略的菌株,以实现高效的光合生物合成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Inducible Mtld expression facilitated the introduction of the mannitol synthesis pathway in Synechococcus elongatus PCC 7942.

Mannitol is a valuable sugar alcohol, extensively used across various industries. Cyanobacteria show potential as future platforms for mannitol production, utilizing CO2 and solar energy directly. The proof-of-concept has been demonstrated by introducing a two-step pathway in cyanobacteria, converting fructose-6-phosphate to mannitol-1-phosphate and sequentially to mannitol. However, recombinant strains generally faced issues of genetic instability or low titers, consequently affecting the long-term mannitol production. In this work, the construction strategy for engineering mannitol production in Synechococcus elongatus PCC 7942, based on commonly adopted pathway comprising mannitol-1-phosphate dehydrogenase (Mtld) and mannitol-1-phosphatase (M1Pase), was optimized. The results demonstrated that the sequential introduction of m1p and mtld was required to obtain mannitol-producing strains. We further manipulated the abundances of Mtld with a theophylline dose-responsive riboswitch approach, and by combining it with the overexpression of m1p, we successfully obtained a recombinant strain producing 1.5 g/L mannitol under optimal conditions, the highest cyanobacterial yield to date. In addition, the controlled expression of mtld was demonstrated to remarkably augment the genetic stability of the mutant under long-term culturing circumstances, which continued to secrete mannitol after more than 2 months of cultivation without the addition of theophylline, and the mannitol biosynthesis operon did not undergo any spontaneous mutation. The findings in this work provided novel insights into the area of cyanobacteria mannitol metabolism engineering, and would inspire researchers to construct strains with different gene regulatory strategies for efficient photosynthetic biosynthesis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信